Evaluation of Omics-Based Strategies for the Management of Advanced Lung Cancer

Omic-informed therapy is being used more frequently for patients with non–small-cell lung cancer (NSCLC) being treated on the basis of evidence-based decision-making. However, there is a lack of a standardized framework to evaluate those decisions and understand the association between omics-based m...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JCO Oncol Pract
Auteurs principaux: Salgia, Ravi, Mambetsariev, Isa, Pharaon, Rebecca, Fricke, Jeremy, Baroz, Angel Ray, Hozo, Iztok, Chen, Chen, Koczywas, Marianna, Massarelli, Erminia, Reckamp, Karen, Djulbegovic, Benjamin
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2021
Sujets:
ORIGINAL CONTRIBUTIONS
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8258019/
https://ncbi.nlm.nih.gov/pubmed/32639928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/OP.20.00117
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires